- Home
- TLSI vs ULBI Comparison
TLSI vs ULBI Comparison
Compare TLSI & ULBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ULBI
- Stock Information
- Founded
- TLSI 2010
- ULBI 1990
- Country
- TLSI United States
- ULBI United States
- Employees
- TLSI N/A
- ULBI N/A
- Industry
- TLSI Medical Specialities
- ULBI Industrial Machinery/Components
- Sector
- TLSI Health Care
- ULBI Miscellaneous
- Exchange
- TLSI Nasdaq
- ULBI Nasdaq
- Market Cap
- TLSI 166.8M
- ULBI 174.9M
- IPO Year
- TLSI N/A
- ULBI 1992
- Fundamental
- Price
- TLSI $4.74
- ULBI $9.62
- Analyst Decision
- TLSI Strong Buy
- ULBI Strong Buy
- Analyst Count
- TLSI 3
- ULBI 1
- Target Price
- TLSI $12.67
- ULBI $14.00
- AVG Volume (30 Days)
- TLSI 77.7K
- ULBI 43.7K
- Earning Date
- TLSI 11-12-2024
- ULBI 10-24-2024
- Dividend Yield
- TLSI N/A
- ULBI N/A
- EPS Growth
- TLSI N/A
- ULBI 283.01
- EPS
- TLSI N/A
- ULBI 0.60
- Revenue
- TLSI $24,736,000.00
- ULBI $168,946,000.00
- Revenue This Year
- TLSI $61.24
- ULBI $10.59
- Revenue Next Year
- TLSI $47.32
- ULBI $8.72
- P/E Ratio
- TLSI N/A
- ULBI $15.90
- Revenue Growth
- TLSI 67.75
- ULBI 17.37
- 52 Week Low
- TLSI $3.32
- ULBI $6.36
- 52 Week High
- TLSI $10.42
- ULBI $13.39
- Technical
- Relative Strength Index (RSI)
- TLSI 35.99
- ULBI 40.08
- Support Level
- TLSI $4.43
- ULBI $9.24
- Resistance Level
- TLSI $5.32
- ULBI $9.69
- Average True Range (ATR)
- TLSI 0.34
- ULBI 0.37
- MACD
- TLSI -0.04
- ULBI -0.04
- Stochastic Oscillator
- TLSI 19.51
- ULBI 18.95
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.